Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium channel activity	RYR2 ITPR2 TRPM1 MCOLN2 CACNA1D CACHD1 CACNA2D4 CACNA2D3	3.98e-05	129	195	8	GO:0005262
GeneOntologyMolecularFunction	UDP-glucose:glycoprotein glucosyltransferase activity	UGGT1 UGGT2	9.49e-05	2	195	2	GO:0003980
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	RYR2 ITPR2 TRPM1 MCOLN2 CACNA1D CACHD1 CACNA2D4 CACNA2D3	1.21e-04	151	195	8	GO:0015085
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase binding	SRC WIF1 CDH5 SMAD6	1.30e-04	27	195	4	GO:0070696
GeneOntologyMolecularFunction	monoatomic cation channel activity	HCN2 RYR2 ITPR2 SCNN1B TRPM1 MCOLN2 CACNA1D KCNAB2 CACHD1 CACNA2D4 SLC4A11 CACNA2D3	1.47e-04	343	195	12	GO:0005261
GeneOntologyMolecularFunction	metallopeptidase activity	MBTPS1 ERAP1 MMP11 EEF1AKMT4-ECE2 PRPF8 AGBL4 TLL1 ENPEP ADAMTSL2	1.59e-04	200	195	9	GO:0008237
GeneOntologyMolecularFunction	U5 snRNA binding	EFTUD2 PRPF8	2.83e-04	3	195	2	GO:0030623
GeneOntologyMolecularFunction	galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity	B3GAT3 B3GAT1	2.83e-04	3	195	2	GO:0015018
GeneOntologyMolecularFunction	histone H3K27 trimethyltransferase activity	EZH1 EZH2	2.83e-04	3	195	2	GO:0140951
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	HCN2 RYR2 ITPR2 MCOLN2	2.89e-04	33	195	4	GO:0005217
GeneOntologyMolecularFunction	receptor serine/threonine kinase binding	SRC WIF1 CDH5 SMAD6	3.64e-04	35	195	4	GO:0033612
GeneOntologyMolecularFunction	histone methyltransferase activity	PRMT8 SMYD1 EZH1 EZH2 EEF1AKMT1	6.52e-04	71	195	5	GO:0042054
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR2 ITPR2 MCOLN2	6.72e-04	18	195	3	GO:0015278
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	HCN2 RYR2 ITPR2 SCNN1B TRPM1 MCOLN2 CACNA1D KCNAB2 CACHD1 SLC9C2 CACNA2D4 SLC4A11 CACNA2D3	6.79e-04	465	195	13	GO:0046873
GeneOntologyMolecularFunction	voltage-gated calcium channel activity	CACNA1D CACHD1 CACNA2D4 CACNA2D3	1.04e-03	46	195	4	GO:0005245
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	SRC FGR FRK LYN	1.04e-03	46	195	4	GO:0004715
GeneOntologyCellularComponent	stereocilia coupling link	MYO7A ADGRV1 WHRN	4.46e-05	8	197	3	GO:0002139
GeneOntologyCellularComponent	stereocilium	MYO7A CDH23 ADGRV1 PTPRQ WHRN PKHD1L1	4.75e-05	69	197	6	GO:0032420
GeneOntologyCellularComponent	cluster of actin-based cell projections	MYO1A MYO7A CDH23 ADGRV1 PTPRQ WHRN CUBN LCT PKHD1L1 ENPEP	5.29e-05	223	197	10	GO:0098862
GeneOntologyCellularComponent	stereocilium bundle	MYO7A CDH23 ADGRV1 PTPRQ WHRN PKHD1L1	1.02e-04	79	197	6	GO:0032421
GeneOntologyCellularComponent	axon	MYO1A SRC IREB2 LRRTM1 HCN2 ADCY9 ITPR2 NF1 TRPM1 DAGLA WHRN AZIN2 KIF21A KCNAB2 SPG11 ARPC3 SPTBN4 AGBL4 TENM3 TNN TANC1	1.08e-04	891	197	21	GO:0030424
GeneOntologyCellularComponent	apical part of cell	MYO1A MYO7A CDH23 PTPRQ SCNN1B PLD1 CACNA1D ABCC1 FN1 DYNC2H1 REN CUBN LCT EDA ENPEP SLC4A11	1.63e-04	592	197	16	GO:0045177
GeneOntologyCellularComponent	Cul4-RING E3 ubiquitin ligase complex	DCAF8 DCAF8L1 DCAF13 DCAF8L2	4.39e-04	38	197	4	GO:0080008
GeneOntologyCellularComponent	tenascin complex	TNC TNN	5.24e-04	4	197	2	GO:0090733
GeneOntologyCellularComponent	USH2 complex	ADGRV1 WHRN	5.24e-04	4	197	2	GO:1990696
GeneOntologyCellularComponent	calcium channel complex	RYR2 CACNA1D CACHD1 CACNA2D4 CACNA2D3	6.31e-04	73	197	5	GO:0034704
GeneOntologyCellularComponent	voltage-gated calcium channel complex	CACNA1D CACHD1 CACNA2D4 CACNA2D3	9.16e-04	46	197	4	GO:0005891
GeneOntologyCellularComponent	stereocilium tip	CDH23 WHRN PKHD1L1	1.11e-03	22	197	3	GO:0032426
GeneOntologyCellularComponent	endoplasmic reticulum lumen	MBTPS1 ERAP1 UGGT1 P3H1 FN1 TNC APOB UGGT2 SERPIND1 IL6	1.26e-03	332	197	10	GO:0005788
GeneOntologyCellularComponent	stereocilia ankle link	ADGRV1 WHRN	1.29e-03	6	197	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	ADGRV1 WHRN	1.29e-03	6	197	2	GO:0002142
GeneOntologyCellularComponent	cochlear hair cell ribbon synapse	CDH23 CACNA1D	1.29e-03	6	197	2	GO:0098683
GeneOntologyCellularComponent	periciliary membrane compartment	ADGRV1 WHRN	1.29e-03	6	197	2	GO:1990075
GeneOntologyCellularComponent	somatodendritic compartment	MYO1A SRC IREB2 HCN2 ADCY9 SERPINI1 NF1 TRPM1 GNAO1 DAGLA WHRN CACNA1D AZIN2 GRK4 KIF21A ARFGEF2 SPG11 APOB PDPK2P SPTBN4 TNN TANC1 SORL1	1.31e-03	1228	197	23	GO:0036477
GeneOntologyCellularComponent	actin-based cell projection	MYO1A MYO7A SRC CDH23 ADGRV1 PTPRQ WHRN CUBN PKHD1L1	1.33e-03	278	197	9	GO:0098858
GeneOntologyCellularComponent	cation channel complex	HCN2 RYR2 SCNN1B CACNA1D KCNAB2 CACHD1 CACNA2D4 CACNA2D3	1.79e-03	235	197	8	GO:0034703
MousePheno	abnormal cochlear hair cell inter-stereocilial links morphology	MYO7A CDH23 ADGRV1 WHRN	2.15e-06	9	163	4	MP:0004577
MousePheno	abnormal orientation of inner hair cell stereociliary bundles	MYO7A CDH23 SEC24B PTPRQ	8.20e-06	12	163	4	MP:0004492
MousePheno	decreased cochlear hair cell stereocilia number	MYO7A CDH23 ADGRV1 PTPRQ WHRN	1.09e-05	26	163	5	MP:0004523
MousePheno	abnormal inner hair cell stereociliary bundle morphology	MYO7A CDH23 ADGRV1 SEC24B PTPRQ WHRN	1.28e-05	45	163	6	MP:0004532
MousePheno	abnormal outer hair cell stereociliary bundle morphology	MYO7A CDH23 ADGRV1 SEC24B PTPRQ WHRN CACNA1D	1.37e-05	68	163	7	MP:0004527
MousePheno	abnormal cochlear outer hair cell physiology	MYO7A CDH23 ADGRV1 WHRN CACNA1D	1.60e-05	28	163	5	MP:0004434
MousePheno	abnormal hair cell physiology	MYO7A CDH23 ADGRV1 PTPRQ WHRN CACNA1D	2.12e-05	49	163	6	MP:0003879
MousePheno	impaired swimming	MYO7A CDH23 HCN2 DOCK3 WHRN TNC CACHD1	4.01e-05	80	163	7	MP:0001522
MousePheno	decreased outer hair cell stereocilia number	MYO7A CDH23 ADGRV1 WHRN	4.80e-05	18	163	4	MP:0004529
MousePheno	abnormal orientation of cochlear hair cell stereociliary bundles	MYO7A CDH23 ADGRV1 SEC24B PTPRQ	4.96e-05	35	163	5	MP:0004522
MousePheno	abnormal cochlear hair cell stereociliary bundle morphology	MYO7A CDH23 ADGRV1 SEC24B PTPRQ WHRN CACNA1D	9.17e-05	91	163	7	MP:0004521
MousePheno	abnormal cochlear hair cell physiology	MYO7A CDH23 ADGRV1 WHRN CACNA1D	9.59e-05	40	163	5	MP:0004432
MousePheno	absent distortion product otoacoustic emissions	MYO7A CDH23 ADGRV1 WHRN CACNA1D	1.08e-04	41	163	5	MP:0004737
MousePheno	abnormal vestibular hair cell stereociliary bundle morphology	MYO7A CDH23 PTPRQ WHRN	1.11e-04	22	163	4	MP:0004515
MousePheno	increased susceptibility to age-related hearing loss	MYO7A CDH23 ADGRV1 PTPRQ	1.33e-04	23	163	4	MP:0004748
MousePheno	abnormal sweat gland physiology	ITPR2 EDA	1.35e-04	2	163	2	MP:0013368
MousePheno	abnormal sweat gland secretion	ITPR2 EDA	1.35e-04	2	163	2	MP:0013369
MousePheno	absent cochlear hair bundle ankle links	MYO7A ADGRV1	1.35e-04	2	163	2	MP:0004582
MousePheno	abnormal cochlear hair bundle ankle links morphology	MYO7A ADGRV1	1.35e-04	2	163	2	MP:0004581
MousePheno	abnormal orientation of outer hair cell stereociliary bundles	MYO7A CDH23 ADGRV1 SEC24B	1.58e-04	24	163	4	MP:0004491
MousePheno	abnormal sensory neuron physiology	MYO7A CDH23 ADGRV1 PTPRQ WHRN CACNA1D	1.90e-04	72	163	6	MP:0010055
MousePheno	abnormal bone marrow cavity morphology	SRC EZH2 FGR LRRK1	2.54e-04	27	163	4	MP:0000065
MousePheno	abnormal vestibular system physiology	MYO7A CDH23 IREB2 SPTBN4 SLC4A11	2.55e-04	49	163	5	MP:0004742
MousePheno	abnormal linear vestibular evoked potential	MYO7A CDH23 SPTBN4 SLC4A11	3.85e-04	30	163	4	MP:0004812
MousePheno	abnormal somatic nervous system physiology	MYO7A CDH23 ADGRV1 PTPRQ WHRN CACNA1D	4.12e-04	83	163	6	MP:0005423
MousePheno	deafness	MYO7A CDH23 ADGRV1 PTPRQ WHRN CACNA1D SPTBN4	4.14e-04	116	163	7	MP:0001967
Domain	VWA_N	CACHD1 CACNA2D4 CACNA2D3	1.10e-05	5	195	3	IPR013608
Domain	VWA_N	CACHD1 CACNA2D4 CACNA2D3	1.10e-05	5	195	3	PF08399
Domain	RCC1	HERC6 RCBTB1 HERC4 HERC5	4.90e-05	20	195	4	PF00415
Domain	RCC1_1	HERC6 RCBTB1 HERC4 HERC5	6.00e-05	21	195	4	PS00625
Domain	RCC1_2	HERC6 RCBTB1 HERC4 HERC5	6.00e-05	21	195	4	PS00626
Domain	RCC1_3	HERC6 RCBTB1 HERC4 HERC5	6.00e-05	21	195	4	PS50012
Domain	-	HERC6 RCBTB1 HERC4 HERC5	7.27e-05	22	195	4	2.130.10.30
Domain	Reg_chr_condens	HERC6 RCBTB1 HERC4 HERC5	7.27e-05	22	195	4	IPR000408
Domain	RCC1/BLIP-II	HERC6 RCBTB1 HERC4 HERC5	8.73e-05	23	195	4	IPR009091
Domain	EZH1/EZH2	EZH1 EZH2	1.08e-04	2	195	2	IPR021654
Domain	CXC	EZH1 EZH2	1.08e-04	2	195	2	PS51633
Domain	EZH2_WD-Binding	EZH1 EZH2	1.08e-04	2	195	2	PF11616
Domain	UDP-g_GGtrans	UGGT1 UGGT2	1.08e-04	2	195	2	IPR009448
Domain	CXC_dom	EZH1 EZH2	1.08e-04	2	195	2	IPR026489
Domain	UDP-g_GGTase	UGGT1 UGGT2	1.08e-04	2	195	2	PF06427
Domain	-	INPP5B CNOT6 DNASE1L1 OCRL	1.44e-04	26	195	4	3.60.10.10
Domain	Exo_endo_phos	INPP5B CNOT6 DNASE1L1 OCRL	1.44e-04	26	195	4	PF03372
Domain	Endo/exonuclease/phosphatase	INPP5B CNOT6 DNASE1L1 OCRL	1.68e-04	27	195	4	IPR005135
Domain	-	UGGT1 B3GAT3 CSGALNACT2 CRPPA UGGT2 B3GAT1	2.03e-04	81	195	6	3.90.550.10
Domain	Peptidase_M1_N	ERAP1 TAF2 ENPEP	2.97e-04	13	195	3	IPR014782
Domain	Peptidase_M1	ERAP1 TAF2 ENPEP	2.97e-04	13	195	3	PF01433
Domain	Rho_GTPase_activation_prot	INPP5B NF1 ARHGAP8 PLXNA2 OCRL ARHGAP35	3.19e-04	88	195	6	IPR008936
Domain	Nucleotide-diphossugar_trans	UGGT1 B3GAT3 CSGALNACT2 CRPPA UGGT2 B3GAT1	3.19e-04	88	195	6	IPR029044
Domain	Glyco_trans_43	B3GAT3 B3GAT1	3.23e-04	3	195	2	IPR005027
Domain	DAPK1	DAPK1 DAPK3	3.23e-04	3	195	2	IPR020676
Domain	Glyco_transf_43	B3GAT3 B3GAT1	3.23e-04	3	195	2	PF03360
Domain	VDCC_a2/dsu	CACNA2D4 CACNA2D3	6.42e-04	4	195	2	IPR013680
Domain	ROC_dom	DAPK1 LRRK1	6.42e-04	4	195	2	IPR020859
Domain	ROC	DAPK1 LRRK1	6.42e-04	4	195	2	PS51424
Domain	VGCC_alpha2	CACNA2D4 CACNA2D3	6.42e-04	4	195	2	PF08473
Domain	-	COL6A5 SEC24B CACHD1 CACNA2D4 CACNA2D3	1.06e-03	74	195	5	3.40.50.410
Domain	Ion_trans_dom	HCN2 RYR2 ITPR2 TRPM1 MCOLN2 CACNA1D	1.26e-03	114	195	6	IPR005821
Domain	Ion_trans	HCN2 RYR2 ITPR2 TRPM1 MCOLN2 CACNA1D	1.26e-03	114	195	6	PF00520
Domain	RIH_assoc-dom	RYR2 ITPR2	1.58e-03	6	195	2	IPR013662
Domain	Tesmin/TSO1-like_CXC	EZH1 EZH2	1.58e-03	6	195	2	IPR033467
Domain	Ins145_P3_rec	RYR2 ITPR2	1.58e-03	6	195	2	PF08709
Domain	RIH_assoc	RYR2 ITPR2	1.58e-03	6	195	2	PF08454
Domain	RIH_dom	RYR2 ITPR2	1.58e-03	6	195	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 ITPR2	1.58e-03	6	195	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 ITPR2	1.58e-03	6	195	2	IPR015925
Domain	-	RYR2 ITPR2	1.58e-03	6	195	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 ITPR2	1.58e-03	6	195	2	PF01365
Domain	CXC	EZH1 EZH2	1.58e-03	6	195	2	SM01114
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	MYO7A CDH23 ADGRV1 ADCY9 PTPRQ WHRN	2.56e-10	16	200	6	17567809
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MBTPS1 FAM234A MANBA ERAP1 UGGT1 B3GAT3 ITPR2 GRAMD1B SERPINI1 NF1 CSGALNACT2 TMEM259 P3H1 SEL1L3 DNASE1L1 ABCC1 TM9SF1 ARFGEF2 RNF213 CACHD1 TXNDC11 TENM3 TLL1 UGGT2 SORL1	3.15e-08	1201	200	25	35696571
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MYO7A CDH23 FMNL2 TULP3 EFTUD2 CNOT6 NF1 SEC24B PTPRQ AGAP3 WHRN IPO8 RB1 DYNC2H1 EML4 RAB11FIP2 SMC4 LARP1 OCRL PRPF8 MTPAP ARPC3 TAF6L TRAPPC10 UGGT2 SORL1	4.96e-08	1321	200	26	27173435
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PDXDC1 INPP5B SRC FMNL2 ADCY9 RYR2 EFTUD2 VPS52 SEC24B PLD1 AGAP3 CDC42BPA FN1 ARFGEF2 RNF213 APOB OCRL PKHD1L1 TENM3	1.41e-07	777	200	19	35844135
Pubmed	Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.	MYO7A CDH23 ADGRV1 WHRN	2.17e-07	10	200	4	24618850
Pubmed	Usher protein functions in hair cells and photoreceptors.	MYO7A CDH23 ADGRV1 WHRN	2.17e-07	10	200	4	24239741
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	PDXDC1 SRC DAPK1 FMNL2 ADCY9 TULP3 NF1 TAF2 PLXNA2 ABCC1 CDC42BPA ARFGEF2 APOB NIBAN2 TANC1 LYN	2.27e-07	569	200	16	30639242
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	MBTPS1 NFATC2 SEL1L3 GNAO1 TSTD2 DAGLA CACNA1D ABCC1 PRPF8 FOXJ3 FRK TENM3 CDH5	2.76e-07	371	200	13	15747579
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PDXDC1 FAM234A SSR3 B3GAT3 FANCD2 VPS52 TMEM259 P3H1 SEC24B OSBPL8 ABCC1 DYNC2H1 TM9SF1 USP24 SMC4 CACHD1 NUP214 OCRL UGGT2 KLHDC4	6.08e-07	942	200	20	31073040
Pubmed	Interaction of protocadherin-15 with the scaffold protein whirlin supports its anchoring of hair-bundle lateral links in cochlear hair cells.	CDH23 ADGRV1 WHRN	7.46e-07	4	200	3	33009420
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO7A DAPK1 DAPK3 LRRTM1 NDUFB3 FMNL2 ITPR2 GRAMD1B NF1 OSBPL8 GNAO1 DAGLA AGAP3 FN1 TNC KCNAB2 ARFGEF2 LARP1 ARHGAP35 ARPC3 SPTBN4 AGBL4 TRAPPC10 TANC1 CACNA2D3	8.35e-07	1431	200	25	37142655
Pubmed	Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.	MYO7A SRC FGR DOCK3 FRK LYN	8.57e-07	56	200	6	22745667
Pubmed	The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome.	SRC FGR FRK LYN	1.02e-06	14	200	4	29568343
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYO7A CSMD2 FMNL2 ITPR2 P3H1 FN1 RB1 KIF21A SMC4 LARP1 RNF213 PRPF8 MTPAP TAF6L EEF1AKMT1 POTEA LYN	1.43e-06	736	200	17	29676528
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ADGRV1 HCN2 ITPR2 NF1 DAGLA AGAP3 FN1 TNC RAB11FIP2 KCNAB2 LARP1 ARPC3 TRAPPC10	1.44e-06	430	200	13	32581705
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	PDXDC1 ERAP1 UGGT1 CNOT6 CDC123 TMEM259 P3H1 SEC24B OSBPL8 MLH1 DCAF13 DUSP3 KIF21A USP24 SMC4 LARP1 APOB NUP214 PRPF8 MTPAP UGGT2 LYN HERC4	1.85e-06	1297	200	23	33545068
Pubmed	IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.	SRC FGR LYN	1.86e-06	5	200	3	21220696
Pubmed	Cochlear outer hair cells undergo an apical circumference remodeling constrained by the hair bundle shape.	MYO7A CDH23 WHRN	1.86e-06	5	200	3	20332152
Pubmed	The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects.	HERC6 HERC4 HERC5	1.86e-06	5	200	3	15676274
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF8 EZH1 FMNL2 ADCY9 FANCD2 VPS52 BRPF1 MLH1 TAF2 PLD1 ANAPC4 AGAP3 RB1 RNF213 MTPAP TAF6L NT5DC2 TANC1 AFF4 SLC4A11 SORL1	2.14e-06	1116	200	21	31753913
Pubmed	Calcium handling precedes cardiac differentiation to initiate the first heartbeat.	MYOM1 RYR2 ITPR2 CACNA1D	2.38e-06	17	200	4	27725084
Pubmed	Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.	SRC FGR LYN	3.70e-06	6	200	3	10861086
Pubmed	Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.	SRC FGR LYN	3.70e-06	6	200	3	16684964
Pubmed	SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages.	TLR4 LYN IL6	3.70e-06	6	200	3	28098138
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC3 SSR3 EZH2 NDUFB3 B3GAT3 CNOT6 CEPT1 NFATC2 SEC24B OSBPL8 MLH1 TAF2 DNASE1L1 AGAP3 CDC42BPA SMC4 FOXJ3 MTPAP ARPC3 NCBP2 TAF6L GZF1 TANC1 AFF4	6.10e-06	1497	200	24	31527615
Pubmed	Endotoxin Tolerance Inhibits Lyn and c-Src Phosphorylation and Association with Toll-Like Receptor 4 but Increases Expression and Activity of Protein Phosphatases.	SRC TLR4 LYN	6.45e-06	7	200	3	26457672
Pubmed	Novel Phosphorylations of IKKγ/NEMO.	SRC FGR LYN	6.45e-06	7	200	3	23131831
Pubmed	Tenascin-C drives persistence of organ fibrosis.	TNC TLR4 IL6	6.45e-06	7	200	3	27256716
Pubmed	Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B.	HERC6 HERC4 HERC5	6.45e-06	7	200	3	18535780
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	PDXDC1 DCAF8 MANBA SSR3 EFTUD2 FANCD2 CEPT1 NF1 CDC123 TMEM259 P3H1 OSBPL8 IPO8 SMC4 PRPF8	6.98e-06	657	200	15	36180527
Pubmed	Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis.	FN1 TNC TNN	1.03e-05	8	200	3	23055981
Pubmed	Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.	SRC FGR LYN	1.03e-05	8	200	3	15190072
Pubmed	Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.	MYO7A CDH23 ADGRV1	1.03e-05	8	200	3	19683999
Pubmed	Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.	SRC FGR LYN	1.03e-05	8	200	3	16921024
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	PLXNA2 WHRN CACHD1 FOXJ3 TSEN2 SPTBN4 RBM12	1.09e-05	130	200	7	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ADGRV1 ADCY9 CNOT6 DAGLA CDC42BPA KIF21A LARP1 SPG11 CACHD1 LRRK1 FOXJ3 RBM12 HERC4	1.35e-05	529	200	13	14621295
Pubmed	Defining the membrane proteome of NK cells.	ERAP1 B3GAT3 ITPR2 EFTUD2 CNOT6 GRAMD1B NF1 CSGALNACT2 P3H1 OSBPL8 MLH1 ETNK1 PLD1 ABCC1 EML4 ARFGEF2 LARP1 RNF213 PRPF8 ARPC3	1.50e-05	1168	200	20	19946888
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	PDXDC1 UGGT1 SRC ADCY9 ITPR2 GRAMD1B CEPT1 TMEM259 SEC24B OSBPL8 ABCC1 UGGT2	1.92e-05	468	200	12	31056421
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	FAM234A IREB2 DAPK1 ST3GAL5 P3H1 SEC24B PLD1 ABCC1 CDC42BPA IPO8 DUSP3 RAB11FIP2 NIBAN2 OCRL TENM3	2.01e-05	719	200	15	35337019
Pubmed	Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.	SRC FGR LYN	2.18e-05	10	200	3	12244095
Pubmed	A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.	MYO7A CDH23 ADGRV1	2.18e-05	10	200	3	17329413
Pubmed	Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2.	EZH1 EZH2	3.29e-05	2	200	2	32428001
Pubmed	IL-6 Generated from Human Hematopoietic Stem and Progenitor Cells through TLR4 Signaling Promotes Emergency Granulopoiesis by Regulating Transcription Factor Expression.	TLR4 IL6	3.29e-05	2	200	2	34341172
Pubmed	Isolation of duplicated human c-src genes located on chromosomes 1 and 20.	SRC FGR	3.29e-05	2	200	2	2581127
Pubmed	PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.	EZH1 EZH2	3.29e-05	2	200	2	28939884
Pubmed	Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase differ in mRNA expression and enzymatic activity.	UGGT1 UGGT2	3.29e-05	2	200	2	10694380
Pubmed	Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1.	EZH1 EZH2	3.29e-05	2	200	2	8921387
Pubmed	Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes.	EZH2 IL6	3.29e-05	2	200	2	25350786
Pubmed	Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF).	FN1 EDA	3.29e-05	2	200	2	18633626
Pubmed	Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration.	EZH1 EZH2	3.29e-05	2	200	2	27526204
Pubmed	Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells.	TLR4 IL6	3.29e-05	2	200	2	18209571
Pubmed	The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer.	EZH2 MLH1	3.29e-05	2	200	2	23523787
Pubmed	Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells.	FN1 TNC	3.29e-05	2	200	2	28986537
Pubmed	Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.	TLR4 IL6	3.29e-05	2	200	2	23134512
Pubmed	NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.	NFATC2 IL6	3.29e-05	2	200	2	29258522
Pubmed	Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4.	FN1 TLR4	3.29e-05	2	200	2	25700433
Pubmed	Founder Ashkenazi Jewish mutations of large deletion in the inherited retinal dystrophy genes.	TRPM1 CACNA2D4	3.29e-05	2	200	2	28726569
Pubmed	X-inactivation analysis of embryonic lethality in Ocrl wt/-; Inpp5b-/- mice.	INPP5B OCRL	3.29e-05	2	200	2	20195868
Pubmed	Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.	SRC LYN	3.29e-05	2	200	2	9353253
Pubmed	Specific enzyme complex of beta-1,4-galactosyltransferase-II and glucuronyltransferase-P facilitates biosynthesis of N-linked human natural killer-1 (HNK-1) carbohydrate.	B3GAT3 B3GAT1	3.29e-05	2	200	2	21771787
Pubmed	Mitochondrial calcium overload is a key determinant in heart failure.	RYR2 ITPR2	3.29e-05	2	200	2	26217001
Pubmed	Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway.	TLR4 IL6	3.29e-05	2	200	2	18948841
Pubmed	Short-term bed rest increases TLR4 and IL-6 expression in skeletal muscle of older adults.	TLR4 IL6	3.29e-05	2	200	2	23761639
Pubmed	Cloning and expression of a human/mouse Polycomb group gene, ENX-2/Enx-2.	EZH1 EZH2	3.29e-05	2	200	2	9473645
Pubmed	Effects of domain composition on catalytic activity of human UDP-glucose:glycoprotein glucosyltransferases.	UGGT1 UGGT2	3.29e-05	2	200	2	27496766
Pubmed	The murine polycomb-group genes Ezh1 and Ezh2 map close to Hox gene clusters on mouse chromosomes 11 and 6.	EZH1 EZH2	3.29e-05	2	200	2	10051331
Pubmed	Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.	FN1 TNC	3.29e-05	2	200	2	23313574
Pubmed	Binding of tenascin-C to soluble fibronectin and matrix fibrils.	FN1 TNC	3.29e-05	2	200	2	7499434
Pubmed	Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.	INPP5B OCRL	3.29e-05	2	200	2	9593760
Pubmed	Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation.	NFATC2 TLR4	3.29e-05	2	200	2	26224862
Pubmed	Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres.	EZH1 EZH2	3.29e-05	2	200	2	9214638
Pubmed	Molecular basis for acceptor substrate specificity of the human beta1,3-glucuronosyltransferases GlcAT-I and GlcAT-P involved in glycosaminoglycan and HNK-1 carbohydrate epitope biosynthesis, respectively.	B3GAT3 B3GAT1	3.29e-05	2	200	2	17567734
Pubmed	Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.	SRC IL6	3.29e-05	2	200	2	17716980
Pubmed	Functional local crosstalk of inositol 1,4,5-trisphosphate receptor- and ryanodine receptor-dependent Ca2+ release in atrial cardiomyocytes.	RYR2 ITPR2	3.29e-05	2	200	2	28158491
Pubmed	PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing.	FN1 PRPF8	3.29e-05	2	200	2	36609600
Pubmed	The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb.	RB1 FRK	3.29e-05	2	200	2	7664264
Pubmed	Cloning of the murine c-fgr proto-oncogene cDNA and induction of c-fgr expression by proliferation and activation factors in normal bone marrow-derived monocytic cells.	FGR LYN	3.29e-05	2	200	2	2674853
Pubmed	Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.	INPP5B OCRL	3.29e-05	2	200	2	21183592
Pubmed	The contribution of GPR98 and DFNB31 genes to a Spanish Usher syndrome type 2 cohort.	ADGRV1 WHRN	3.29e-05	2	200	2	23441107
Pubmed	A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles.	MYO7A PTPRQ	3.29e-05	2	200	2	14534255
Pubmed	Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts.	SRC ARHGAP35	3.29e-05	2	200	2	11309200
Pubmed	Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling.	FN1 TLR4	3.29e-05	2	200	2	32555351
Pubmed	Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway.	SRC ARHGAP35	3.29e-05	2	200	2	23178654
Pubmed	De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.	FN1 TNC	3.29e-05	2	200	2	24792713
Pubmed	Toll-Like Receptor 4 and Tenascin-C Signaling in Cerebral Vasospasm and Brain Injuries After Subarachnoid Hemorrhage.	TNC TLR4	3.29e-05	2	200	2	31407069
Pubmed	Characterization of recombinant human glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans.	B3GAT3 B3GAT1	3.29e-05	2	200	2	10526176
Pubmed	EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair.	EZH1 EZH2	3.29e-05	2	200	2	21317239
Pubmed	Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.	TLR4 IL6	3.29e-05	2	200	2	22596222
Pubmed	Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms.	EZH1 EZH2	3.29e-05	2	200	2	27311868
Pubmed	USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy.	USP24 IL6	3.29e-05	2	200	2	30266897
Pubmed	The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.	EZH1 EZH2	3.29e-05	2	200	2	25477280
Pubmed	Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase.	INPP5B OCRL	3.29e-05	2	200	2	19700499
Pubmed	Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes.	SRC TLR4	3.29e-05	2	200	2	20379791
Pubmed	Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.	EZH1 EZH2	3.29e-05	2	200	2	31747604
Pubmed	An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.	EZH2 NFATC2	3.29e-05	2	200	2	30710146
Pubmed	The noncatalytic portion of human UDP-glucose: glycoprotein glucosyltransferase I confers UDP-glucose binding and transferase function to the catalytic domain.	UGGT1 UGGT2	3.29e-05	2	200	2	12913004
Pubmed	Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active.	UGGT1 UGGT2	3.29e-05	2	200	2	24415556
Pubmed	The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC.	CDH23 ADGRV1	3.29e-05	2	200	2	15820310
Pubmed	Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.	EZH1 EZH2	3.29e-05	2	200	2	30689973
Pubmed	Palmitoylation-dependent endosomal localization of AATYK1A and its interaction with Src.	SRC AATK	3.29e-05	2	200	2	18691334
Interaction	RAB11A interactions	PDXDC1 SRC DAPK1 THSD1 EZH2 ADCY9 ITPR2 FANCD2 CDC123 SEC24B OSBPL8 GNAO1 PLD1 ABCC1 CDC42BPA FN1 RAB11FIP2 ARFGEF2 CACHD1 NIBAN2 OCRL NCBP2 TRAPPC10 B3GAT1	1.89e-06	830	196	24	int:RAB11A
Interaction	GPR17 interactions	PDXDC1 ERAP1 NDUFB3 ITPR2 FANCD2 VPS52 IPO8 USP24 ARFGEF2 RNF213 SPG11 EDA UBR3	4.29e-06	283	196	13	int:GPR17
Interaction	RAB35 interactions	PDXDC1 EZH2 FMNL2 ADCY9 TULP3 FANCD2 CDC123 OSBPL8 PLD1 ABCC1 CDC42BPA FN1 ARFGEF2 CACHD1 NIBAN2 OCRL TANC1 LYN	1.32e-05	573	196	18	int:RAB35
GeneFamily	UDP-glucose glycoprotein glucosyltransferases	UGGT1 UGGT2	5.37e-05	2	133	2	440
GeneFamily	Beta-1,3-glucuronyltransferases	B3GAT3 B3GAT1	1.60e-04	3	133	2	423
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 WHRN	3.19e-04	4	133	2	1244
GeneFamily	Ankyrin repeat domain containing\|Death associated protein kinases	DAPK1 DAPK3	5.29e-04	5	133	2	1021
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	EZH1 EZH2	7.90e-04	6	133	2	1347
GeneFamily	Calcium voltage-gated channel subunits	CACNA1D CACNA2D4 CACNA2D3	8.94e-04	26	133	3	253
GeneFamily	SH2 domain containing	SRC FGR FRK HSH2D LYN	9.00e-04	101	133	5	741
GeneFamily	Fibronectin type III domain containing	MYOM1 PTPRQ FN1 TNC TNN SORL1	1.19e-03	160	133	6	555
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SMYD1 EZH1 EZH2	1.97e-03	34	133	3	487
GeneFamily	Serpin peptidase inhibitors	SERPINA4 SERPINI1 SERPIND1	2.52e-03	37	133	3	739
Coexpression	CHESLER_BRAIN_QTL_CIS	PDXDC1 DCAF8 MYO7A TULP3 VPS52 EEF1AKMT1 SORL1	1.35e-06	73	198	7	M17500
Coexpression	NICK_RESPONSE_TO_PROC_TREATMENT_DN	ERAP1 ITPR2 TMEM259 ETNK1 SPG11	1.65e-06	27	198	5	M8801
Coexpression	CHESLER_BRAIN_QTL_CIS	PDXDC1 DCAF8 MYO7A TULP3 VPS52 EEF1AKMT1 SORL1	1.78e-06	76	198	7	MM611
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	SRC PPP4R1L SERPINA4 DDX60L HERC6 AZIN2 RNF213 PPM1K HERC5	1.93e-05	196	198	9	M4267
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	DAPK1 CSMD3 FMNL2 RYR2 ITPR2 SERPINI1 ST3GAL5 P3H1 SEL1L3 PLD1 PLXNA2 CACNA1D ABCC1 CDC42BPA GRK4 RAB11FIP2 RNF213 CACHD1 FOXJ3 TAF6L RLIM HERC4	3.04e-06	791	192	22	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200	DAPK1 FMNL2 RYR2 PLD1 RAB11FIP2 RNF213	1.69e-05	60	192	6	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000	DAPK1 FMNL2 RYR2 ITPR2 SERPINI1 PLD1 CACNA1D RAB11FIP2 RNF213 CACHD1 RLIM	1.89e-05	251	192	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000	TKTL1 RYR2 ITPR2 SERPINI1 GRK4 RAB11FIP2 RNF213 PPM1K ERMAP UGGT2	3.21e-05	219	192	10	gudmap_developingGonad_e16.5_ovary_1000_k5
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	DAPK1 COL6A5 FMNL2 RYR2 TULP3 ITPR2 SERPINI1 PLD1 RAB11FIP2 RNF213 CACHD1	3.69e-05	270	192	11	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500	TKTL1 RYR2 SERPINI1 GRK4 RNF213 PPM1K ERMAP	7.63e-05	113	192	7	gudmap_developingGonad_e16.5_ovary_500_k3
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FMNL2 ST3GAL5 HERC6 MCOLN2 FN1 RNF213 PPM1K HSH2D CDH5 HERC5	1.37e-08	187	200	10	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FMNL2 NFATC2 SEL1L3 PLXNA2 ABCC1 TNC EML4 NIBAN2 TENM3 IL6	1.76e-08	192	200	10	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL6A5 RYR2 PLXNA2 MCOLN2 CACNA1D FN1 TNC TANC1 ADAMTSL2 CACNA2D3	1.85e-08	193	200	10	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	MYO7A COL6A5 RYR2 GNAO1 MCOLN2 CACNA1D DYNC2H1 AATK TENM3 WIF1	2.36e-08	198	200	10	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	CDH23 COL6A5 RYR2 MCOLN2 CACNA1D FN1 TNC IL6 ADAMTSL2	1.81e-07	187	200	9	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	MANBA GRAMD1B CSGALNACT2 SEL1L3 DDX60L FGR KCNAB2 LRRK1 LYN	2.17e-07	191	200	9	3b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	RYR2 OSBPL8 PLXNA2 MCOLN2 CACNA1D FN1 TNC TENM3 TANC1	2.27e-07	192	200	9	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	RA\|World / Chamber and Cluster_Paper	NFATC2 PTPRQ GNAO1 FN1 AGBL4 UGGT2 IL6 ADAMTSL2 SMAD6	2.48e-07	194	200	9	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CDH23 RYR2 CSGALNACT2 OSBPL8 CACNA1D FN1 TNC TENM3 TANC1	2.82e-07	197	200	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MANBA FMNL2 ITPR2 FN1 EML4 KCNAB2 RNF213 TLR4	1.25e-06	174	200	8	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	356C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SSR3 SEL1L3 SCNN1B SMOX PKHD1L1 TXNDC11 NT5DC2 UGGT2	2.32e-06	189	200	8	0994aba7a44577a8943af237c9c3575502d0584c
ToppCell	356C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SSR3 SEL1L3 SCNN1B SMOX PKHD1L1 TXNDC11 NT5DC2 UGGT2	2.32e-06	189	200	8	d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRMT8 ADGRV1 SEL1L3 DOCK3 KIF21A TLL1 WIF1 SORL1	2.81e-06	194	200	8	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	MANBA CSGALNACT2 SEL1L3 DDX60L FGR KCNAB2 LRRK1 LYN	2.92e-06	195	200	8	ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A5 RYR2 MCOLN2 CACNA1D FN1 DYNC2H1 TNC TENM3	3.40e-06	199	200	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MANBA DAPK1 FGR FN1 KCNAB2 ARFGEF2 TLR4 LYN	3.40e-06	199	200	8	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A5 ADGRV1 RYR2 PTPRQ PKHD1L1 TLL1 CACNA2D3	8.11e-06	160	200	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A5 ADGRV1 RYR2 PTPRQ PKHD1L1 TLL1 CACNA2D3	8.11e-06	160	200	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 ADGRV1 CSMD3 RYR2 CUBN PKHD1L1 IL6	1.16e-05	169	200	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A5 ADGRV1 GRAMD1B MMP11 FN1 ENPEP SORL1	1.20e-05	170	200	7	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCNN1B CMKLR2 FRK TLL1 TLR4 LYN CDH5	1.45e-05	175	200	7	43be63976da5ad0764d24d90919a77ce46068f52
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ERAP1 TKTL1 CSGALNACT2 FGR AGAP3 FN1 KCNAB2	1.68e-05	179	200	7	6624a2e731ab2d6c2eec19445e3dc509f581a8a9
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_NK\|GI_small-bowel / Manually curated celltypes from each tissue	TKTL1 FGR WIF1 HSH2D B3GAT1 LYN SORL1	1.68e-05	179	200	7	535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	PRMT8 DAPK1 ADGRV1 SCNN1B CACHD1 NIBAN2 FRK	1.81e-05	181	200	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FMNL2 RYR2 DOCK3 CACNA1D TNC CRPPA WIF1	1.94e-05	183	200	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	DDX60L RNF213 PPM1K HSH2D IL6 AFF4 HERC5	1.94e-05	183	200	7	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19_Mild-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CSMD2 ADCY9 P3H1 SLC9C2 CYP2U1 TANC1	2.07e-05	124	200	6	5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK1 ADGRV1 ST3GAL5 PLXNA2 KIF21A FRK CACNA2D3	2.08e-05	185	200	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	P07-Endothelial-capillary_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD1 DUSP3 ARPC3 WIF1 LYN CDH5 SMAD6	2.15e-05	186	200	7	72aab20b848dd9e1101a4bc2466e08aed5f8bbb6
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	PRMT8 ADGRV1 SERPINI1 SEL1L3 SCNN1B CUBN TLL1	2.23e-05	187	200	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	B_cells-Plasma_cells_and_plasmablasts\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SSR3 SCNN1B SMOX LRRK1 PKHD1L1 TXNDC11 NT5DC2	2.23e-05	187	200	7	9325cadd5f2c667d526696899e7aa36a98226d4b
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	SSR3 SEL1L3 SCNN1B LRRK1 PKHD1L1 TXNDC11 NT5DC2	2.30e-05	188	200	7	c7b1807c96f87fbcd37739a159cf00f9a1ff5d71
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR2 ETNK1 FN1 SMC4 PKHD1L1 TRIM47 SMAD6	2.38e-05	189	200	7	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	DAPK1 ITPR2 PLXNA2 FN1 PKHD1L1 TLL1 SMAD6	2.38e-05	189	200	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	DAPK1 ITPR2 PLXNA2 FN1 PKHD1L1 TLL1 SMAD6	2.38e-05	189	200	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	P07-Endothelial\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD1 DUSP3 ARPC3 WIF1 LYN CDH5 SMAD6	2.38e-05	189	200	7	d62b5b5c3cd259befa7afb19f45e3804e2ab80f7
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD1 SCNN1B CMKLR2 PKHD1L1 TLL1 UBR3 CDH5	2.47e-05	190	200	7	32400c62cb9de4c2b24af4206c21a0215ab12212
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD1 SCNN1B CMKLR2 PKHD1L1 TLL1 UBR3 CDH5	2.47e-05	190	200	7	b2bd2cb384bb8a5662064ed1aee68e905e1f780d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRMT8 DAPK1 LRRTM1 CSMD2 ITPR2 WHRN SORL1	2.47e-05	190	200	7	1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	DDX60L HERC6 RNF213 PPM1K HSH2D IL6 HERC5	2.55e-05	191	200	7	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAPK1 ADGRV1 ST3GAL5 PTPRQ PLXNA2 CACHD1 WIF1	2.55e-05	191	200	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	MANBA DAPK1 FMNL2 FGR EML4 KCNAB2 LYN	2.55e-05	191	200	7	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD1 SCNN1B CMKLR2 PKHD1L1 TLL1 LYN CDH5	2.64e-05	192	200	7	5388f3115ab285f3f3001af1d71543ed64b9e044
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 SEL1L3 DOCK3 KIF21A AGBL4 WIF1 SORL1	2.64e-05	192	200	7	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MANBA DAPK1 FMNL2 FGR EML4 KCNAB2 LYN	2.64e-05	192	200	7	bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCell	CV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	DDX60L HERC6 RNF213 PPM1K CACNA2D4 HSH2D HERC5	2.64e-05	192	200	7	2a2052b44e8f679ef484f03ba4fb37b0ec841b88
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD1 SCNN1B CMKLR2 PKHD1L1 TLL1 LYN CDH5	2.73e-05	193	200	7	ef007b736da56529ec628fc3df86a335e7ec3f18
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FMNL2 ST3GAL5 FN1 RNF213 HSH2D CDH5 HERC5	2.82e-05	194	200	7	e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	CSGALNACT2 DDX60L HERC6 RNF213 TXNDC11 HSH2D HERC5	2.82e-05	194	200	7	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	PND01-Mesenchymal-Mesenchymal_structural\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EZH2 CACNA1D FN1 PPM1K NT5DC2 ENPEP ADAMTSL2	2.91e-05	195	200	7	6bb6349d6ec8da094fe1c7c590021989337aeb0b
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 SMYD1 RYR2 GRAMD1B DOCK3 KIF21A PPM1K	2.91e-05	195	200	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	Macrophages-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	FMNL2 CEPT1 CSGALNACT2 GNAO1 FGR FN1 HERC5	2.91e-05	195	200	7	e48bf57e6da23fbb4637a02387155f825455c49f
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EZH2 CACNA1D FN1 PPM1K NT5DC2 ENPEP ADAMTSL2	2.91e-05	195	200	7	a3b468125e48f072255cede7645f6692298ecf54
ToppCell	MS-plasma\|MS / Condition, Cell_class and T cell subcluster	SSR3 SEL1L3 SCNN1B PKHD1L1 TXNDC11 NT5DC2 HSH2D	2.91e-05	195	200	7	de866c0eaec36d94a3101eb9f949ca9544207f33
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 SMYD1 RYR2 GRAMD1B DOCK3 KIF21A PPM1K	2.91e-05	195	200	7	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	MS-plasma-\|MS / Condition, Cell_class and T cell subcluster	SSR3 SEL1L3 SCNN1B PKHD1L1 TXNDC11 NT5DC2 HSH2D	2.91e-05	195	200	7	b0a51dea06899e6a4477c3436c85e114cd8f6214
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRK4 PKHD1L1 BCO1 SPTBN4 AGBL4 TENM3 TLL1	3.01e-05	196	200	7	96e5c6d155273e82ebafa180df8bb589c3e3e54e
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRK4 PKHD1L1 BCO1 SPTBN4 AGBL4 TENM3 TLL1	3.01e-05	196	200	7	ce13af36fc2932e8125013041742593ff3d07e86
ToppCell	C_05\|World / shred on cell type and cluster	SCNN1B DDX60L HERC6 MCOLN2 RNF213 MUC12 HERC5	3.01e-05	196	200	7	bf4dfb460a153dbafb2b9b12b360c8757cec22cd
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 PLXNA2 KIF21A NIBAN2 FRK CACNA2D3	3.07e-05	133	200	6	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SLCO1C1 MMP11 FN1 DYNC2H1 TNC TANC1 ENPEP	3.11e-05	197	200	7	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFATC2 MCOLN2 FN1 KIF21A NIBAN2 WIF1 TRIM47	3.11e-05	197	200	7	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EZH2 CACNA1D FN1 PPM1K NT5DC2 ENPEP ADAMTSL2	3.11e-05	197	200	7	d35c7a36135b5ed6a7bf2f934849678eba2a0177
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	DAPK1 DDX60L HERC6 RNF213 PPM1K HSH2D HERC5	3.21e-05	198	200	7	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDH23 COL6A5 RYR2 MCOLN2 CACNA1D FN1 TENM3	3.21e-05	198	200	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	COL6A5 PLXNA2 MCOLN2 CACNA1D FN1 PPM1K TANC1	3.21e-05	198	200	7	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TM7SF3 NFATC2 P3H1 FN1 TNC TENM3 WIF1	3.21e-05	198	200	7	524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD3 RYR2 SERPINI1 OSBPL8 CACNA1D SPTBN4 AGBL4	3.21e-05	198	200	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A5 OSBPL8 MCOLN2 FN1 TNC TANC1 ENPEP	3.31e-05	199	200	7	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A5 OSBPL8 MCOLN2 FN1 TNC TANC1 ENPEP	3.31e-05	199	200	7	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CDH23 NFATC2 PLD1 LRRK1 FRK TLR4 TRAPPC10	3.42e-05	200	200	7	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR2 MCOLN2 CACNA1D FN1 TENM3 ENPEP ADAMTSL2	3.42e-05	200	200	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CDH23 NFATC2 PLD1 LRRK1 FRK TLR4 TRAPPC10	3.42e-05	200	200	7	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	Control_saline-Endothelial-Endothelial-Activated_Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	THSD1 HERC6 RNF213 TANC1 CDH5 ADAMTSL2 HERC5	3.42e-05	200	200	7	be55cef682ba87250dad97689332c8820b3a7420
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	THSD1 SLCO1C1 ARHGAP8 FN1 CDH5 SMAD6	4.79e-05	144	200	6	1c118b22c2ff3a526a5207d6c9d772636ee065fd
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	ST3GAL5 P3H1 SMOX FN1 KIF21A ERMAP	5.38e-05	147	200	6	87c24843cb0e87ad42e725d08423131a5d2d25a3
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	THSD1 SLCO1C1 ARHGAP8 FN1 CDH5 SMAD6	5.80e-05	149	200	6	d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRQ HSH2D MTFR2 SLC4A11 ADAMTSL2 CACNA2D3	6.02e-05	150	200	6	9cb3332924bd67c966873343c14445e30d3f384f
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAPK1 TKTL1 SERPINI1 UGGT2 IL6 MITD1	7.75e-05	157	200	6	3c6be6995c00c4cadbd209c66bf9a87c8c238652
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAPK1 TKTL1 SERPINI1 UGGT2 IL6 MITD1	7.75e-05	157	200	6	662d5026e0e4249029fc6f3abc771d775d7bc3bb
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	EZH1 AGAP3 CACNA1D FN1 TLL1 ADAMTSL2	7.75e-05	157	200	6	4183dbed6b31ebe13ef33eb19ba6d0fb4f625953
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SSR3 SEL1L3 LRRK1 PKHD1L1 TXNDC11 HSH2D	7.75e-05	157	200	6	63502d0fd5972d71cdbe13bde167592c70acec32
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDH23 TKTL1 RYR2 AZIN2 TNC TENM3	8.02e-05	158	200	6	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEL1L3 SCNN1B LRRK1 PPM1K TXNDC11 HSH2D	8.02e-05	158	200	6	6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEL1L3 SCNN1B LRRK1 PPM1K TXNDC11 HSH2D	8.02e-05	158	200	6	8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888
ToppCell	LAM-Lymphoid-B-cell-2\|LAM / Condition, Lineage and Cell class	SSR3 SEL1L3 SCNN1B WHRN PKHD1L1 HSH2D	8.60e-05	160	200	6	0060c2b3304f411c682aa2ba20bcf80f346d2403
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCHD3 CSMD3 RYR2 SLCO1C1 FN1 WIF1	8.90e-05	161	200	6	b9a17f41426bf715f30bf544a6795afaf37a3aa6
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCHD3 CSMD3 RYR2 SLCO1C1 FN1 WIF1	8.90e-05	161	200	6	f7a89c481f789f624102857be722c95fbeb47595
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRPF1 NBPF3 CDC42BPA FN1 AATK CDH5	9.52e-05	163	200	6	1feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MBTPS1 UGGT1 WHRN LRRK1 PKHD1L1 TXNDC11	1.02e-04	165	200	6	6e8370b8e747d8ef44a2413a993291a3cd83a77c
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRAMD1B GNAO1 MCOLN2 LRRK1 CACNA2D4 SLC4A11	1.02e-04	165	200	6	d8b0a9b6f704b98e8f0412c11739879a26c036e2
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITPR2 RGMA SCNN1B MMP11 HSH2D TRIM47	1.09e-04	167	200	6	7ec032a98a13504d15c7e3a4e259278d07f40180
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SMYD1 COL6A5 DOCK3 CMKLR2 TNC PKHD1L1	1.09e-04	167	200	6	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITPR2 RGMA SCNN1B MMP11 HSH2D TRIM47	1.09e-04	167	200	6	49d9220f22d10ff06c0512c9c40c26ad51728e4f
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SMYD1 COL6A5 DOCK3 CMKLR2 TNC PKHD1L1	1.09e-04	167	200	6	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEL1L3 BPIFC SMC4 LCT TXNDC11 HSH2D	1.09e-04	167	200	6	0130743084dbcb20e10f96715d30961122150cbf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEL1L3 BPIFC SMC4 LCT TXNDC11 HSH2D	1.09e-04	167	200	6	7bcae3797d3a0811e7f39885afdfd29ec517f11b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEL1L3 BPIFC SMC4 LCT TXNDC11 HSH2D	1.09e-04	167	200	6	c6f0209a1ad797631fdfa3efab6db6b1d3e8e315
ToppCell	3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITPR2 RGMA SCNN1B MMP11 HSH2D TRIM47	1.09e-04	167	200	6	5e3588eee73693a996bb4846427cf0038ceafbca
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL6A5 RYR2 AZIN2 PCDHB3 KLHDC4 ENPEP	1.12e-04	168	200	6	1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c
Drug	fullerene C60	FAM234A MYO1A MYO7A SRC THSD1 PP2D1 NDUFB3 TMEM259 PTPRQ ETNK1 MMP11 DAGLA PLXNA2 AGAP3 LRRC63 WHRN CACNA1D DUSP3 PCDHB3 CACHD1 NIBAN2 LRRK1 TXNDC11 BCO1 TAF6L TRAPPC10 CYP2U1 B3GAT1 IL6 AFF4 ADAMTSL2 HERC5 CACNA2D3 SMAD6	1.66e-07	1498	195	34	ctd:C069837
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A	ITPR2 DAGLA ABCC1 CDC42BPA TNC KCNAB2 NUP214 LRRK1 EDA TAF6L IL6	1.18e-06	198	195	11	7390_UP
Drug	AC1OAGFB	SRC CDH23 HCN2 ADCY9 TULP3 SERPINA4 SCNN1B PLD1 DAGLA AGAP3 FN1 GRK4 OCRL ARHGAP35 ARPC3 TXNDC11 SPTBN4	4.31e-06	539	195	17	CID006857345
Drug	cyclophorine	DAPK3 ADCY9 RYR2 NFATC2 TRPM1 CACNA1D ABCC1 USP24 APOB REN NUP214 EDA CACNA2D4 IL6 CACNA2D3	4.35e-06	426	195	15	CID000002909
Drug	iron arsenate	SRC SERPINA4 RB1	6.11e-06	5	195	3	CID000024938
Drug	ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A	INPP5B DAPK3 RYR2 ITPR2 NF1 TMEM259 PLXNA2 GRK4 TAF6L LYN	6.77e-06	193	195	10	7490_UP
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A	INPP5B SRC ITPR2 NF1 PLXNA2 SMC4 ZNF419 LYN HERC4 HERC5	7.42e-06	195	195	10	4393_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DAPK3 NF1 MMP11 DAGLA DCAF13 RB1 NUP214 ARHGAP35 TAF6L HERC4	7.76e-06	196	195	10	3847_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; PC3; HT_HG-U133A	IREB2 EZH1 NF1 TMEM259 P3H1 PLXNA2 FN1 TNC LRRK1 ERMAP	7.76e-06	196	195	10	5723_DN
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	DCAF8 INPP5B DAPK3 EZH1 ITPR2 TMEM259 FOXJ3 TRAPPC10 LYN ENPEP	8.11e-06	197	195	10	1507_DN
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EZH1 CDC42BPA DYNC2H1 USP24 TAF6L RBM12 RCBTB1 UGGT2 SMAD6 SORL1	8.48e-06	198	195	10	6256_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; PC3; HT_HG-U133A	SRC EZH1 ADCY9 ST3GAL5 RB1 RAB11FIP2 KCNAB2 APOB EDA B3GAT1	8.48e-06	198	195	10	4661_UP
Drug	gadolinium	CDH23 ADGRV1 RYR2 GH2 NF1 ST3GAL5 TRPM1 CACNA1D CACNA2D4 CACNA2D3	8.87e-06	199	195	10	CID000023982
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	EZH1 TMEM259 GNAO1 PLD1 IPO8 RB1 EDA TAF6L ENPEP AFF4	8.87e-06	199	195	10	7226_UP
Drug	Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	ST3GAL5 TMEM259 WHRN CACNA1D ARHGAP35 AATK TENM3 ERMAP LYN HERC4	9.26e-06	200	195	10	6521_DN
Drug	EC27	RB1 REN ENPEP	1.21e-05	6	195	3	CID000168100
Drug	myo-inositol	MBTPS1 SRC ADCY9 RYR2 TULP3 SERPINA4 CEPT1 NF1 NFATC2 GNAO1 PLD1 DAGLA CACNA1D CMKLR2 OCRL LCT CACNA2D4 B3GAT1 LYN CACNA2D3	2.31e-05	811	195	20	CID000000892
Drug	lanthanum	CDH23 ADCY9 RYR2 CACNA1D NUP214 CACNA2D4 ERMAP CACNA2D3	2.32e-05	136	195	8	CID000023926
Drug	irbesartan	ERAP1 CACNA1D APOB REN IL6	4.05e-05	45	195	5	ctd:C081309
Drug	CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A	ERAP1 INPP5B DCAF13 IPO8 EML4 LRRK1 HERC4 IL6 HERC5	4.16e-05	191	195	9	7549_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	INPP5B IREB2 ITPR2 ABCC1 IPO8 EML4 LRRK1 OCRL TENM3	4.51e-05	193	195	9	6751_DN
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	ERAP1 EZH1 GRAMD1B CDC42BPA FN1 RB1 RAB11FIP2 LRRK1 KLHDC4	4.88e-05	195	195	9	2956_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	DAPK3 ITPR2 SLCO1C1 TMEM259 DCAF13 FN1 RB1 KCNAB2 ARHGAP35	4.88e-05	195	195	9	3862_UP
Drug	DB01788	SERPINA4 FN1 ERMAP	5.00e-05	9	195	3	CID004635105
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A	INPP5B ST3GAL5 HERC6 DAGLA DCAF13 FN1 ARFGEF2 ARHGAP35 HERC5	5.08e-05	196	195	9	5345_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	EZH1 ADCY9 NF1 TMEM259 WHRN IPO8 SMC4 TAF6L FRK	5.29e-05	197	195	9	4836_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	THSD1 EZH1 RYR2 ABCC1 CDC42BPA IPO8 TAF6L FRK AFF4	5.29e-05	197	195	9	3566_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	INPP5B B3GAT3 NF1 TMEM259 IPO8 DUSP3 ARHGAP35 ZNF419 ENPEP	5.29e-05	197	195	9	3456_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	DAPK3 CDC42BPA DYNC2H1 RAB11FIP2 OCRL RBM12 TRAPPC10 UGGT2 LYN	5.29e-05	197	195	9	6949_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SSR3 EZH1 P3H1 BRPF1 IPO8 FOXJ3 ZNF419 ERMAP ENPEP	5.50e-05	198	195	9	3466_DN
Drug	N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	INPP5B THSD1 EPM2AIP1 NF1 ST3GAL5 IPO8 DYNC2H1 ARHGAP35 ENPEP	5.50e-05	198	195	9	842_UP
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	PRMT8 INPP5B EZH1 PLD1 DAGLA DCAF13 NUP214 LRRK1 TAF6L	5.72e-05	199	195	9	2120_UP
Drug	Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A	MYO7A ERAP1 NF1 GNAO1 PLXNA2 KCNAB2 TAF6L AATK HERC5	5.72e-05	199	195	9	3552_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	ERAP1 INPP5B EZH1 NF1 HERC6 IPO8 TAF6L AATK ENPEP	5.72e-05	199	195	9	6357_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	MANBA ERAP1 THSD1 ADCY9 NF1 WHRN OCRL ARHGAP35 ERMAP	5.72e-05	199	195	9	4297_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A	DCAF8 DAPK3 TULP3 NF1 DCAF13 DYNC2H1 USP24 SMC4 HERC4	5.72e-05	199	195	9	6491_DN
Drug	N-cyclopentyl-N-cyclobutylformamide	RYR2 CACNA1D REN CACNA2D4 IL6 CACNA2D3	6.04e-05	79	195	6	CID005287890
Drug	Sandonorm	APOB REN	7.30e-05	2	195	2	CID000636368
Drug	FR901464	MLH1 ABCC1	7.30e-05	2	195	2	CID006448738
Drug	N-Formylmethionine Leucyl-Phenylalanine	SRC PLD1 FGR LYN IL6	7.47e-05	51	195	5	ctd:D009240
Drug	benazepril	CACNA1D FN1 APOB REN TLR4 IL6	8.53e-05	84	195	6	ctd:C044946
Drug	geldanamycin	UGGT1 SRC NF1 OSBPL8 PLXNA2 IPO8 FN1 PPM1K TLL1 TLR4 IL6 AFF4	9.08e-05	371	195	12	ctd:C001277
Drug	3',4'-dihydroxyflavone	ABCC1 FN1 IL6	9.70e-05	11	195	3	ctd:C028288
Disease	colorectal cancer (implicated_via_orthology)	SRC MLH1 FGR FRK LYN	1.35e-06	30	191	5	DOID:9256 (implicated_via_orthology)
Disease	kidney disease (implicated_via_orthology)	SRC FGR CUBN LCT LYN	6.69e-06	41	191	5	DOID:557 (implicated_via_orthology)
Disease	diabetes mellitus (is_marker_for)	FN1 APOB ARPC3 TLR4 IL6	6.69e-06	41	191	5	DOID:9351 (is_marker_for)
Disease	Hereditary retinal dystrophy	MYO7A CDH23 WHRN	9.17e-06	7	191	3	C0154860
Disease	Colorectal Carcinoma	SRC CSMD3 NF1 SCNN1B MLH1 MMP11 ANAPC4 ABCC1 FN1 APOB CUBN EDA TLR4 WIF1 CDH5 SORL1	1.48e-05	702	191	16	C0009402
Disease	phosphatidylcholine 38:4 measurement	PDXDC1 ADGRV1 ITPR2 DAGLA	3.08e-05	28	191	4	EFO_0010386
Disease	keratitis (is_implicated_in)	TLR4 IL6	4.17e-05	2	191	2	DOID:4677 (is_implicated_in)
Disease	hearing impairment	MYO1A MYO7A CDH23 ADGRV1 WHRN TLR4	4.37e-05	98	191	6	C1384666
Disease	uric acid measurement	ADGRV1 EZH2 ADCY9 NFATC2 GNAO1 ANAPC4 CDC42BPA DYNC2H1 PPM1K CUBN FRK TANC1 HERC4 CACNA2D3	4.77e-05	610	191	14	EFO_0004761
Disease	intestinal cancer (implicated_via_orthology)	SRC FGR FRK LYN	5.31e-05	32	191	4	DOID:10155 (implicated_via_orthology)
Disease	iron deficiency anemia (biomarker_via_orthology)	IREB2 FN1 IL6	7.28e-05	13	191	3	DOID:11758 (biomarker_via_orthology)
Disease	Malignant neoplasm of breast	ERCC3 SRC EZH2 NF1 SCNN1B SMOX ABCC1 FN1 RB1 DYNC2H1 SMARCAL1 ARFGEF2 NUP214 CUBN TLL1 CDH5 ENPEP IL6 SORL1	7.58e-05	1074	191	19	C0006142
Disease	Ciliopathies	MYO7A CDH23 ADGRV1 SCNN1B WHRN DYNC2H1	8.33e-05	110	191	6	C4277690
Disease	Nonsyndromic Deafness	MYO7A CDH23 ADGRV1 WHRN TNC	1.85e-04	81	191	5	C3711374
Disease	melanoma	ERCC3 MYO7A NF1 TNC CUBN EDA MTPAP TLR4	2.25e-04	248	191	8	C0025202
Disease	Liddle Syndrome	SCNN1B REN	2.48e-04	4	191	2	C0221043
Disease	Hypertensive disease	ERAP1 SCNN1B ABCC1 FN1 REN TLR4 IL6	2.50e-04	190	191	7	C0020538
Disease	Lung Injury	TNC TLR4 IL6	3.26e-04	21	191	3	C0273115
Disease	Chronic Lung Injury	TNC TLR4 IL6	3.26e-04	21	191	3	C2350344
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A CDH23 PTPRQ WHRN	3.35e-04	51	191	4	cv:CN043650
Disease	Usher Syndrome, Type II	MYO7A WHRN	4.12e-04	5	191	2	C1568249
Disease	USHER SYNDROME, TYPE IB (disorder)	MYO7A CDH23	4.12e-04	5	191	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	MYO7A CDH23	4.12e-04	5	191	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	MYO7A CDH23	4.12e-04	5	191	2	C1848640
Disease	Usher syndrome, type 1A	MYO7A CDH23	4.12e-04	5	191	2	C2931205
Disease	Usher syndrome type 1	MYO7A CDH23	4.12e-04	5	191	2	cv:C1568247
Disease	Peripheral Nervous System Diseases	ERCC3 DAPK1 ABCC1 IL6	4.18e-04	54	191	4	C4721453
Disease	sciatic neuropathy (biomarker_via_orthology)	RGMA NF1 CACNA1D TLR4 IL6	4.71e-04	99	191	5	DOID:11446 (biomarker_via_orthology)
Disease	Disorder of eye	MYO7A CDH23 ADGRV1 TRPM1 WHRN PRPF8 CACNA2D4	4.83e-04	212	191	7	C0015397
Disease	Behcet Syndrome	ERAP1 APOB TLR4	4.89e-04	24	191	3	C0004943
Disease	alpha-linolenic acid measurement	PDXDC1 DAGLA LCT	5.53e-04	25	191	3	EFO_0007759
Disease	colon cancer (is_marker_for)	SRC EZH2 NF1 MLH1	5.86e-04	59	191	4	DOID:219 (is_marker_for)
Disease	Usher Syndrome, Type I	MYO7A CDH23	6.15e-04	6	191	2	C1568247
Disease	small cell carcinoma (is_marker_for)	WIF1 IL6	6.15e-04	6	191	2	DOID:0050685 (is_marker_for)
Disease	psychosis predisposition measurement	CNOT6 ABCC1 REN	6.22e-04	26	191	3	EFO_0008337
Disease	urinary bladder cancer (is_marker_for)	EZH2 MLH1 FN1 RB1 WIF1	6.72e-04	107	191	5	DOID:11054 (is_marker_for)
Disease	carcinoma (implicated_via_orthology)	SRC FGR EDA LYN	7.98e-04	64	191	4	DOID:305 (implicated_via_orthology)
Disease	Developmental regression	ST3GAL5 NUP214	8.57e-04	7	191	2	C1836830
Disease	Usher syndrome	MYO7A CDH23	8.57e-04	7	191	2	cv:C0271097
Disease	binge eating	ARHGAP8 CUBN	1.14e-03	8	191	2	EFO_0005924
Disease	obsolete_red blood cell distribution width	FAM234A MYO1A INPP5B CDH23 EZH2 ADCY9 ST3GAL5 TMEM259 PLD1 SMOX DAGLA ABCC1 LARP1 APOB TXNDC11 ERMAP HSH2D LYN SMAD6	1.24e-03	1347	191	19	EFO_0005192
Disease	sensorineural hearing loss (is_implicated_in)	MYO1A MYO7A WHRN	1.26e-03	33	191	3	DOID:10003 (is_implicated_in)
Disease	Neoplasm Invasiveness	SRC IREB2 FN1 TLR4 IL6 SORL1	1.30e-03	184	191	6	C0027626
Disease	diet measurement	PDXDC1 GH2 RGMA NF1 GNAO1 DAGLA ANAPC4 CMKLR2 RAB11FIP2 ARFGEF2 APOB FRK AATK TLL1 UBR3 SORL1	1.38e-03	1049	191	16	EFO_0008111
Disease	Middle Cerebral Artery Embolus	PLD1 SMOX IL6	1.38e-03	34	191	3	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	PLD1 SMOX IL6	1.38e-03	34	191	3	C0751847
Disease	Left Middle Cerebral Artery Infarction	PLD1 SMOX IL6	1.38e-03	34	191	3	C0751846
Disease	Right Middle Cerebral Artery Infarction	PLD1 SMOX IL6	1.38e-03	34	191	3	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	PLD1 SMOX IL6	1.38e-03	34	191	3	C0751848
Disease	Vasodilators used in cardiac diseases use measurement	DYNC2H1 RNF213 APOB	1.38e-03	34	191	3	EFO_0009926
Disease	Middle Cerebral Artery Occlusion	PLD1 SMOX IL6	1.38e-03	34	191	3	C0740391
Disease	Infarction, Middle Cerebral Artery	PLD1 SMOX IL6	1.38e-03	34	191	3	C0740392
Disease	Middle Cerebral Artery Thrombosis	PLD1 SMOX IL6	1.38e-03	34	191	3	C0740376
Disease	Middle Cerebral Artery Syndrome	PLD1 SMOX IL6	1.38e-03	34	191	3	C0238281
Disease	plasma renin activity measurement	TXNDC11 TENM3	1.46e-03	9	191	2	EFO_0006828
Disease	Renal Cell Carcinoma	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	1.50e-03	128	191	5	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	1.50e-03	128	191	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	1.50e-03	128	191	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	1.50e-03	128	191	5	C1266044
Disease	Papillary Renal Cell Carcinoma	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	1.50e-03	128	191	5	C1306837
Disease	Nonsyndromic genetic hearing loss	MYO7A CDH23 PTPRQ WHRN	1.52e-03	76	191	4	cv:C5680182
Disease	Abnormality of refraction	TKTL1 ITPR2 RGMA GRAMD1B TRPM1 DAGLA DOCK3 CACNA1D RCBTB1 TLL1 SLC4A11 SMAD6	1.54e-03	673	191	12	HP_0000539
Disease	colorectal carcinoma (is_marker_for)	SRC EZH2 NF1	1.76e-03	37	191	3	DOID:0080199 (is_marker_for)
Disease	pleural tuberculosis (is_marker_for)	TNC TLR4	1.81e-03	10	191	2	DOID:106 (is_marker_for)
Disease	Facies	AFF4 ADAMTSL2	1.81e-03	10	191	2	C0282631
Disease	Pleural Diseases	TNC IL6	1.81e-03	10	191	2	C0032226
Disease	hair colour measurement, eye colour measurement, skin pigmentation measurement	SERPINI1 RAB11FIP2	1.81e-03	10	191	2	EFO_0007009, EFO_0007822, EFO_0009764
Disease	depressive disorder (is_marker_for)	REN IL6	1.81e-03	10	191	2	DOID:1596 (is_marker_for)
Disease	ankylosing spondylitis (is_marker_for)	TLR4 IL6	1.81e-03	10	191	2	DOID:7147 (is_marker_for)
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR2 TNC CDH5 SMAD6	1.83e-03	80	191	4	DOID:6432 (biomarker_via_orthology)
Disease	forced expiratory volume	IREB2 RYR2 CDC123 GNAO1 ANAPC4 CACNA1D IPO8 EML4 GRK4 ARFGEF2 LARP1 HERC5 CACNA2D3	1.99e-03	789	191	13	EFO_0004314
Disease	Cardiomegaly	SRC ITPR2 PLD1 REN	2.01e-03	82	191	4	C0018800
Disease	Cardiac Hypertrophy	SRC ITPR2 PLD1 REN	2.01e-03	82	191	4	C1383860
Disease	degree of unsaturation measurement	PDXDC1 DUSP3 APOB	2.06e-03	39	191	3	EFO_0022261
Disease	acute myeloid leukemia (is_implicated_in)	EZH2 NF1 NUP214 IL6	2.19e-03	84	191	4	DOID:9119 (is_implicated_in)
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPA RNF213	2.21e-03	11	191	2	DOID:0060669 (implicated_via_orthology)
Disease	coagulation factor XA measurement	WHRN ABCC1	2.21e-03	11	191	2	EFO_0020266
Disease	migraine disorder, fasting blood glucose measurement	FAM234A MANBA	2.21e-03	11	191	2	EFO_0004465, MONDO_0005277
Disease	beta thalassemia (is_marker_for)	APOB IL6	2.21e-03	11	191	2	DOID:12241 (is_marker_for)
Disease	lysophosphatidylcholine 20:3 measurement	PDXDC1 NFATC2 DAGLA	2.21e-03	40	191	3	EFO_0010362
Disease	bilirubin measurement	FAM234A TKTL1 SLCO1C1 GNAO1 APOB CACHD1 BCO1 TLL1 IL6	2.46e-03	442	191	9	EFO_0004570
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	PDXDC1 DAGLA	2.64e-03	12	191	2	OBA_2045157
Disease	carpal tunnel syndrome	GNAO1 CRPPA ADAMTSL2 SMAD6	2.71e-03	89	191	4	EFO_0004143
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PDXDC1 DAPK1 CSMD3 SPTBN4 IL6	2.83e-03	148	191	5	C0279702
Disease	IIeocolitis	FN1 TLR4 IL6	2.91e-03	44	191	3	C0949272
Disease	Crohn's disease of the ileum	FN1 TLR4 IL6	2.91e-03	44	191	3	C0267380
Disease	Regional enteritis	FN1 TLR4 IL6	2.91e-03	44	191	3	C0678202
Disease	Crohn's disease of large bowel	FN1 TLR4 IL6	2.91e-03	44	191	3	C0156147
Disease	Neoplasm Metastasis	DAPK1 MLH1 RB1 EML4 TLR4 IL6	2.98e-03	217	191	6	C0027627
Disease	lung disease (implicated_via_orthology)	TLR4 IL6	3.10e-03	13	191	2	DOID:850 (implicated_via_orthology)
Disease	skin melanoma (is_marker_for)	FANCD2 AFF4	3.10e-03	13	191	2	DOID:8923 (is_marker_for)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 PTPRQ	3.10e-03	13	191	2	C1846647
Disease	pneumonia	PRMT8 IREB2 GNAO1	3.51e-03	47	191	3	EFO_0003106
Disease	Non-Small Cell Lung Carcinoma	DAPK1 MMP11 RB1 EML4 DUSP3	3.54e-03	156	191	5	C0007131
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	PDXDC1 DAGLA	3.60e-03	14	191	2	EFO_0022085
Disease	body weights and measures, parental genotype effect measurement	NLRP13 CRPPA	3.60e-03	14	191	2	EFO_0004324, EFO_0005939
Disease	malignant pleural mesothelioma (is_marker_for)	EZH2 MLH1	3.60e-03	14	191	2	DOID:7474 (is_marker_for)
Disease	lysophosphatidylcholine 22:5 measurement	NFATC2 DAGLA	3.60e-03	14	191	2	EFO_0021462
Disease	trimethylamine-N-oxide measurement	ITPR2 CUBN	3.60e-03	14	191	2	EFO_0010541
Disease	upper face morphology measurement	ADGRV1 GNAO1 RAB11FIP2 SLC4A11	3.69e-03	97	191	4	EFO_0010949

Protein segments in the cluster

Peptide	Gene	Start	Entry
VYFADDDNTYSLELF	B3GAT1	191	Q9P2W7
LEDEISFQTVYNYFL	AGAP3	166	Q96P47
YSAAVIYDFLAVDDI	FAM234A	86	Q9H0X4
LANVSAVNYEFEDEY	DAPK1	226	P53355
YFADDDNTYSRELFE	B3GAT3	191	O94766
LSLVYNSEDSAEYQF	ANAPC4	671	Q9UJX5
YFLSEKQYDEFEIFD	CSMD2	2401	Q7Z408
VFQSFALEEEYDYLS	CSMD3	106	Q7Z407
YSELVAEFYNTFSNI	ACER1	21	Q8TDN7
DIFAELGRYYVTSAF	AZIN2	271	Q96A70
LYEFIEIEFSVQDRY	EXOC1L	21	A0A1B0GW35
EVQVADFASFLEFVY	GZF1	81	Q9H116
FYIQDSDDVYGLITF	ADGRV1	506	Q8WXG9
EVYFFVELYEATAGA	ADGRV1	5461	Q8WXG9
LYAICDVFTQFYEAL	ARFGEF2	1406	Q9Y6D5
DVNLAYILEDVTYYQ	CACHD1	486	Q5VU97
NDYVHALVTYFNIEF	PRMT8	301	Q9NR22
DYEYIQQYSFIVEAT	CDH5	326	P33151
YETVDRYDFDLFANE	CDH23	421	Q9H251
AFIFTAANEDYNLYT	DCAF13	251	Q9NV06
YVNEVFNFSVDKLYD	GRAMD1B	376	Q3KR37
FEKAVYYLDAVVSFI	AFF4	936	Q9UHB7
AAFVVAVGAEYYLES	NDUFB3	76	O43676
EEEYDSIIVFYNSVF	RB1	746	P06400
TVSIDEILDFFYGYQ	RBM12	866	Q9NTZ6
YVTDNDEVFVFGLNY	RCBTB1	36	Q8NDN9
FDFAQLTDEVLYFAV	PPM1K	111	Q8N3J5
AGYAFEYLIETLNDS	IREB2	6	P48200
YALQSFDYEQFRDLE	PCDHGA11	516	Q9Y5H2
NYLEYNADLFQAITD	P3H1	256	Q32P28
FYSFLLFDLVYREET	ITPR2	2366	Q14571
AFLFDVIYEAYQQCS	CRPPA	216	A4D126
TEFLQFYEDQYGVAL	NIBAN2	26	Q96TA1
REYYFAEAQIADFSD	SERPIND1	241	P05546
EAYEDDSNVKFFYLN	OVOS1	436	Q6IE37
DELDFSILFDYEYLN	NFATC2	26	Q13469
IEYYFSVDNLERDFF	LARP1	411	Q6PKG0
NLSFYTTEEQIYELF	NCBP2	46	P52298
EFSSTVVEYEYIVAF	MBTPS1	46	Q14703
EYLQSFLEDYFTSAE	FGR	506	P09769
AREFDIFYQSYEELG	LRRK1	1991	Q38SD2
EYAQGEDVLDAVYAF	LRRTM1	346	Q86UE6
YFRSEAALTLADFIY	MYO1A	766	Q9UBC5
VNDFEFHVYNRSDLY	KIAA1109	131	Q2LD37
LKNIAFYYEFESTQE	DDX60L	366	Q5H9U9
ELLASYNDDDIYLFN	DCAF8L2	436	P0C7V8
YALDAAVTLLEFYED	ERAP1	281	Q9NZ08
ELFFDYRYSQADALK	EZH2	721	Q15910
DTLALVSHFDIFYIY	PLXNA2	231	O75051
SRYEDFVVDGFNVLY	PDXDC1	156	Q6P996
DTLDEYFEYDAEEFL	FAM214A	6	Q32MH5
YFEYDAEEFLVSLAL	FAM214A	11	Q32MH5
ELLASYNDEDIYLFN	DCAF8	401	Q5TAQ9
QNRQEFVDAYVDYIF	HERC4	891	Q5GLZ8
FVDAYVDYIFNKSVA	HERC4	896	Q5GLZ8
DYIFNVSVKAVYEEF	HERC6	861	Q8IVU3
LTNISAVNYDFDEEY	DAPK3	226	O43293
ELCRENFSIYIFEYD	EEF1AKMT1	91	Q8WVE0
FDDSLRVDYFNQYIN	LCT	766	P09848
AFLSQRYYEDLDEVS	NUP214	971	P35658
ADVLALADEAGYYFF	ADAMTSL2	251	Q86TH1
FSLSYLEELDVSYNE	LRRC63	411	Q05C16
YAANITKSVFDYFEE	ENPEP	321	Q07075
TFQDDEKLYFGLSYA	PDPK2P	121	Q6A1A2
DGDNTDFRYFIYAVT	GPR174	11	Q9BXC1
YEDDSNVKFFYLVSL	OVOS2	466	Q6IE36
FYESFGLYAVVEFCQ	MTPAP	106	Q9NVV4
ANVDYEDLFLYSNAV	HSH2D	131	Q96JZ2
AYDNGINLFDTAEVY	KCNAB2	76	Q13303
ELSDLDYNVEYSAYV	PTPRQ	951	Q9UMZ3
YIFNDSVKAVYEEFR	HERC5	871	Q9UII4
LYAVNSFDYEKFREF	PCDHAC2	531	Q9Y5I4
ATDYFLQQKDYFIIF	OSBPL8	861	Q9BZF1
YRSAFYSFEEQDVSL	NBPF3	591	Q9H094
SFDEEYLFYIIGDLF	CYP2U1	336	Q7Z449
TDSDLAYEGFLINYE	CUBN	1026	O60494
YFVALFDYQARTAED	FRK	46	P42685
NYFKELFETIAREFY	DYNC2H1	196	Q8NCM8
DVYDGYEISEDSFFQ	EEF1AKMT4-ECE2	631	P0DPD8
YINFTDFASYEVVVD	EDA	311	Q92838
EYQADYESLRFFSLL	APOB	1601	P04114
DFSDQLSDYYEKFIA	APOB	4501	P04114
LIFNENDFVEGYYRT	CSGALNACT2	211	Q8N6G5
LLFLDQYFNSFIDEY	CEPT1	356	Q9Y6K0
ESLEFLKVDYVNYNF	BPIFC	66	Q8NFQ6
LSSYVYNDEDDVFAR	DNASE1L1	111	P49184
YNTIGEDTDVFFSLY	DOCK3	226	Q8IZD9
IQYKFLDEDFVFDIY	CDC123	221	O75794
IVDEAIYYFKANVFF	ARPC3	41	O15145
EFDADLQYEYFNAVL	CACNA2D3	121	Q8IZS8
SLALDDQAFVAYENY	EPM2AIP1	176	Q7L775
IFEDFVDSSVGYYTV	FN1	1311	P02751
EYNFEDLSASFRSLY	FOXJ3	286	Q9UPW0
EFNESLVFDYYNSVL	CACNA2D4	156	Q7Z3S7
EVEFYITDYSNDIDL	COL6A5	491	A8TX70
NIDAISGFAYEYTLE	FAIM	66	Q9NVQ4
EDDFLYVAYSNESVY	GABARAPL3	101	Q9BY60
AFCFDREEDIYQFAY	AGBL4	151	Q5VU57
FASIVNFSEFYEENY	ADCY9	1061	O60503
LVEYLSFAQYAVTFD	FMNL2	136	Q96PY5
FENENTFYIYGVSDL	MANBA	696	O00462
QDEYIVEYSLEYGFL	TMEM259	206	Q4ZIN3
DYLQSVLDDFYTATE	LYN	491	P07948
QSDAYSEIAYLFAEF	DAGLA	211	Q9Y4D2
FNLSAYFERAADFID	DUSP3	96	P51452
EEDYTYIQNFRFFAG	INPP5B	336	P32019
EESLSGEFFNDLYFY	KLHDC4	321	Q8TBB5
LASYNDEDIYLFNSS	DCAF8L1	406	A6NGE4
YFIASVVVLFNYEER	EML4	286	Q9HC35
VAEEYNAFFYSLVSQ	ERCC3	651	P19447
FNEFAGVSDVDYSLY	ETNK1	346	Q9HBU6
YLDTADEDFYARFAT	GRK4	491	P32298
EDRTEAAFSYYEFLL	SEC24B	1246	O95487
NIYFQEFNYRTIEES	SCNN1B	496	P51168
LDEFTTLARDLYAFY	RYR2	3356	Q92736
YSLSVDNFNEVLEEY	HCN2	631	Q9UL51
LYFVDLQDDLDDYGF	PPP4R1L	6	Q9P1A2
YFDYAFTAIFTVEIL	CACNA1D	921	Q01668
VSLQEVETEQYYSFF	CNOT6	236	Q9ULM6
VYTQEDAYESIFFAI	MCOLN2	121	Q8IZK6
EFEVYLEYLQNRFES	IL6	121	P05231
AFIYFDQYAAILEDT	PTCHD3	786	Q3KNS1
QASALYYDEFANLIQ	FANCD2	626	Q9BXW9
YLNFEAINSYEVDIE	PCDHB3	306	Q9Y5E6
DFDAATYLALINAVY	SERPINI1	171	Q99574
IASEDYDLLFSNYET	POTEA	426	Q6S8J7
GILYEVFQQDCFEYF	IPO8	676	O15397
QVDLFRDITFYVYFS	ABCC1	166	P33527
IDAAFQDADGYAYFL	MMP11	436	P24347
FLDYEAGVISFYNVT	ERMAP	361	Q96PL5
EDAVYYAFKISFIFL	TAS2R39	106	P59534
TLADIYRELYAFFGD	TAF6L	436	Q9Y6J9
YRIFEYLQLSLEEAF	TSEN2	291	Q8NCE0
FQFLYTYIAEVDGEI	ROPN1B	161	Q9BZX4
AVLDSYEYFAVLAAK	MRPS10	86	P82664
VICDDYDLDFNSFYA	SLC4A11	431	Q8NBS3
TFEYLQAFLEDYFTS	SRC	511	P12931
INEYYIADASEDQVF	SORL1	346	Q92673
DYFLKFAYIVDLDSD	TRIM47	421	Q96LD4
QSVAYKDFIYFTVFE	SEL1L3	76	Q68CR1
LYAVYDQAVSIFYDL	SMAD6	346	O43541
YDYVELFDGLDSTAV	TLL1	946	O43897
AVSFFDDVTVYLFDQ	AATK	1231	Q6ZMQ8
FSYESLFREYLNETV	MITD1	101	Q8WV92
YIYIENQFFISCADD	PLD1	776	Q13393
TVFIDEAYVEVAAYA	TAF2	306	Q6P1X5
ADFAFRFYYLIASET	SERPINA4	56	P29622
EDVFSFYYNRDSENS	REN	221	P00797
TYEDAAAYIQAQFES	GNAO1	296	P09471
AYFEADISYSQDLIA	SMARCAL1	341	Q9NZC9
LSYLQAFEEASFYAR	SMYD1	361	Q8NB12
SDLEYYSNDLFVAVL	ST3GAL5	251	Q9UNP4
DLAAFYGDAETVLYL	TANC1	1216	Q9C0D5
SDQLLFDQYTAEGLY	WHRN	101	Q9P202
SEELFYQILIYDFAN	MLH1	556	P40692
YLSVYSENAVDIFDV	CDC42BPA	1461	Q5VT25
GDVNFTLAAYYALED	RGMA	386	Q96B86
EFQELLLEYSELFYE	ARHGAP35	491	Q9NRY4
FQELDLSTEAFFYFE	OCRL	276	Q01968
NEVADYEATTFSIFY	SSR3	126	Q9UNL2
NLEAYRYLNFDDFEE	BRPF1	681	P55201
FDVIAYEDNSLYQLF	BCO1	321	Q9HAY6
ETLFEEFENYSYDLD	CMKLR2	6	P46091
LTDLVDDNYFYLFDL	PRPF8	246	Q6P2Q9
FYQASIVAEAYDFVP	SPG11	2331	Q96JI7
LYQLAYDTYQEFEEA	GH2	46	P01242
VYSLLFADQLSYEVA	RNF213	1891	Q63HN8
DSYLADCYDAIAVFL	VPS52	431	Q8N1B4
TANESAYAIYDFFQV	TNN	1166	Q9UQP3
AYAIYDFFQVASSKE	TNN	1171	Q9UQP3
FDYVFDIDSQQEQIY	KIF21A	51	Q7Z4S6
AFYQFVNNLSEEDYR	RLIM	31	Q9NVW2
ALSNDTVYVDFQYFD	THSD1	36	Q9NS62
YLDDFASEDNAAFYI	SLCO1C1	211	Q9NYB5
AIQAGEELFFDYRYS	EZH1	716	Q92800
EELFFDYRYSQADAL	EZH1	721	Q92800
VEEFSDLYNEVYNLT	SMOX	136	Q9NWM0
AYEYFFIQVQEADTV	TNC	1191	P24821
SVFLNDIYYASEIEE	NF1	1776	P21359
DFKNVSIVAFYIYEQ	SMC4	1226	Q9NTJ3
VLDAAFQVEQYYFDV	SPTBN4	1616	Q9H254
FQVEQYYFDVAEVEA	SPTBN4	1621	Q9H254
YGEIYFDSNIDFQLV	TENM3	2321	Q9P273
QAEYFYEFLSLRSLD	WIF1	96	Q9Y5W5
FVFDERYALSYNSDV	TSTD2	401	Q5T7W7
AFSENRQDYFDYEST	RAB11FIP2	391	Q7L804
FVVKYFRDYETDFNL	PKHD1L1	681	Q86WI1
DVEVYGFDYDYTLAQ	NT5DC2	66	Q9H857
FADILYVANDEEASY	MTFR2	76	Q6P444
TLDQYVENDYTIVYF	ARHGAP8	61	P85298
ILFLEFRTYDDFSYQ	TRPM1	761	Q7Z4N2
AAALDSFYLKEQTFY	TXNDC11	496	Q6PKC3
LYVREQQDAYEFFTS	USP24	1766	Q9UPU5
VEFESQTYYAAFAAE	UBR3	561	Q6ZT12
TAYQYFESSLIDEDL	SLC9C2	1001	Q5TAH2
YDELDALFSQYVVNF	TRAPPC10	246	P48553
FNYIAEEFDISEAFI	UGGT2	541	Q9NYU1
DFYAEDFYLLEKITF	UGGT2	886	Q9NYU1
IYADTFGDINYQEFA	EFTUD2	326	Q15029
YVTFEDVAVYFSQEE	ZNF419	26	Q96HQ0
AYLDYYLDDIIDLFN	TLR4	291	O00206
ENIYDAFVIYSSQDE	TLR4	671	O00206
ASAAAFYYVFEISET	TMEM251	51	Q8N6I4
FGRVADDVFTLDYNY	TULP3	406	O75386
ASYYSLDNLVAIFDV	TKTL1	141	P51854
YLDLTASNNFFVDDY	UGGT1	706	Q9NYU2
QAIEELYYFEFVVDD	TM9SF1	121	O15321
IYLEYNFFETTIKFA	TM7SF3	151	Q9NS93
FYTVFREEYAAIEDL	PP2D1	251	A8MPX8
ADYTLEYEELFENLA	MUC12	5241	Q9UKN1
YAYFFSNLFSTAEVD	NLRP13	456	Q86W25
DDLAELASQQYFVDY	MYO7A	1386	Q13402
EQYSAYVFVRDADAE	MYOM1	491	P52179